{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:41Z","timestamp":1789886381397,"version":"4.0.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40292-018-0252-5","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T05:33:00Z","timestamp":1519363980000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The Role of Renin\u2013Angiotensin\u2013Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-572X","authenticated-orcid":false,"given":"Mario Fritsch","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rosa","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Rabello","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Altenburg","family":"Gismondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wille","family":"Oigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"252_CR1","first-page":"1","volume":"4","author":"JL Zhuo","year":"2013","unstructured":"Zhuo JL, Ferrao FM, Zheng Y, Li XC. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms. Front Endocrinol (Lausanne). 2013;4:1\u201314.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"252_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Riet Te","year":"2015","unstructured":"Te Riet L, Van Esch JHM, Roks AJM, Van Den Meiracker AH, Danser AHJ. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116:960\u201375.","journal-title":"Circ Res"},{"key":"252_CR3","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","volume":"116","author":"S Oparil","year":"2015","unstructured":"Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116:1074\u201395.","journal-title":"Circ Res"},{"key":"252_CR4","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1161\/01.CIR.0000069826.36125.B4","volume":"107","author":"ME Safar","year":"2003","unstructured":"Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:2864\u20139.","journal-title":"Circulation"},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236\u201341.","journal-title":"Hypertension"},{"key":"252_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000065428.03209.64","volume":"34","author":"S Laurent","year":"2003","unstructured":"Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203\u20136.","journal-title":"Stroke"},{"key":"252_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"252_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00004872-200303000-00004","volume":"21","author":"JI Davies","year":"2003","unstructured":"Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003;21:463\u201372.","journal-title":"J Hypertens"},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/HJH.0b013e328346a583","volume":"29","author":"KT Ong","year":"2011","unstructured":"Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, Boutouyrie PI. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens. 2011;29:1034\u201342.","journal-title":"J Hypertens"},{"key":"252_CR10","doi-asserted-by":"publisher","first-page":"f2195","DOI":"10.1136\/bmj.f2195","volume":"346","author":"P Strazzullo","year":"2013","unstructured":"Strazzullo P. Reducing sodium and increasing potassium intake. BMJ. 2013;346:f2195.","journal-title":"BMJ"},{"key":"252_CR11","doi-asserted-by":"publisher","first-page":"b4567","DOI":"10.1136\/bmj.b4567","volume":"339","author":"P Strazzullo","year":"2009","unstructured":"Strazzullo P, D\u2019Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.","journal-title":"BMJ"},{"key":"252_CR12","doi-asserted-by":"publisher","first-page":"f1326","DOI":"10.1136\/bmj.f1326","volume":"346","author":"NJ Aburto","year":"2013","unstructured":"Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326.","journal-title":"BMJ"},{"key":"252_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","volume":"334","author":"NR Cook","year":"2007","unstructured":"Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885\u20138.","journal-title":"BMJ"},{"key":"252_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MNH.0000000000000089","volume":"24","author":"DG Edwards","year":"2015","unstructured":"Edwards DG, Farquhar WB. Vascular effects of dietary salt. Curr Opin Nephrol Hypertens. 2015;24:8\u201313.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"252_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HJH.0000000000001186","volume":"35","author":"L D\u2019Elia","year":"2017","unstructured":"D\u2019Elia L, Galletti F, La Fata E, Sabino P, Strazzullo P. Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials. J Hypertens. 2017;35:1\u201310.","journal-title":"J Hypertens"},{"key":"252_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3945\/ajcn.2009.28645","volume":"91","author":"AS Todd","year":"2010","unstructured":"Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland WH, et al. Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 2010;91:557\u201364.","journal-title":"Am J Clin Nutr"},{"key":"252_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.088328","volume":"50","author":"ED Frohlich","year":"2007","unstructured":"Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50:161\u20136.","journal-title":"Hypertension."},{"key":"252_CR18","doi-asserted-by":"publisher","first-page":"H814","DOI":"10.1152\/ajpheart.00671.2006","volume":"292","author":"LC Matavelli","year":"2007","unstructured":"Matavelli LC, Zhou X, Varagic J, Susic DFE. Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Hear Circ Physiol. 2007;292:H814\u20139.","journal-title":"Am J Physiol Hear Circ Physiol."},{"key":"252_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11906-002-0037-y","volume":"4","author":"FH Leenen","year":"2002","unstructured":"Leenen FH, Ruzicka M, Huang BS. The brain and salt-sensitive hypertension. Curr Hypertens Rep. 2002;4:129\u201335.","journal-title":"Curr Hypertens Rep."},{"key":"252_CR20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/HYPERTENSIONAHA.107.091694","volume":"50","author":"O Schmidlin","year":"2007","unstructured":"Schmidlin O, Forman A, Sebastian AMRJ. Sodium-selective salt sensitivity: its occurrence in blacks. Hypertension. 2007;50:1085\u201392.","journal-title":"Hypertension"},{"key":"252_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1113\/expphysiol.2008.046326","volume":"95","author":"JWFG Osborn","year":"2010","unstructured":"Osborn JWFG. Region specific changes in sympathetic nerve activity in AngII-salt hypertension. Exp Physiol. 2010;95:61\u20138.","journal-title":"Exp Physiol"},{"key":"252_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.physbeh.2010.04.024","volume":"100","author":"SD Stocker","year":"2010","unstructured":"Stocker SD, Madden CJSA. Excess dietary salt intake alters the excitability of central sympathetic networks. Physiol Behav. 2010;100:519\u201324.","journal-title":"Physiol Behav"},{"key":"252_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"252_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.artres.2012.03.002","volume":"6","author":"KM M\u00e4ki-Pet\u00e4j\u00e4","year":"2012","unstructured":"M\u00e4ki-Pet\u00e4j\u00e4 KM, Wilkinson IB. Inflammation and large arteries: potential mechanisms for inflammation-induced arterial stiffness. Artery Res. 2012;6:59\u201364.","journal-title":"Artery Res."},{"key":"252_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jcjd.2015.01.004","volume":"39","author":"H Ayhan","year":"2015","unstructured":"Ayhan H, Kasapkara HA, Aslan AN, Durmaz T, Kele\u015f T, Ak\u00e7ay M, et al. Relationship of neutrophil-to-lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus. Can J Diabetes. 2015;39:317\u201321.","journal-title":"Can J Diabetes."},{"key":"252_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.artres.2011.10.002","volume":"5","author":"A Avolio","year":"2011","unstructured":"Avolio A, Butlin M, Liu YY, Viegas K, Avadhanam B, Lindesay G. Regulation of arterial stiffness: cellular, molecular and neurogenic mechanisms. Artery Res. 2011;5:122\u20137.","journal-title":"Artery Res."},{"key":"252_CR27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.jacc.2003.06.016","volume":"42","author":"CM McEniery","year":"2003","unstructured":"McEniery CM, Qasem A, Schmitt M, Avolio AP, Cockcroft JR, Wilkinson IB. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol. 2003;42:1975\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"252_CR28","doi-asserted-by":"crossref","unstructured":"Lacolley P, Challande P, Regnault V, Lakattac EG, Wang M. Cellular and molecular determinants of arterial aging. In: Nilsson P, Olsen M, Laurent S, editors. Early Vascular Aging. Elsevier, Academic Press; 2015. p. 7\u201313.","DOI":"10.1016\/B978-0-12-801387-8.00002-8"},{"key":"252_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2013.10.002","volume":"25","author":"M Wang","year":"2014","unstructured":"Wang M, Jiang L, Monticone RE, Lakatta EG. Proinflammation: the key to arterial aging. Trends Endocrinol Metab. 2014;25:72\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"252_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/01.ATV.19.7.1623","volume":"19","author":"R Kranzhofer","year":"1999","unstructured":"Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"252_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0014-5793(94)00531-1","volume":"347","author":"AW Hahn","year":"1994","unstructured":"Hahn AW, Jonas U, Buhler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett. 1994;347:178\u201380.","journal-title":"FEBS Lett"},{"key":"252_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","volume":"98","author":"CM Ferrario","year":"2006","unstructured":"Ferrario CM, Strawn WB. Role of the renin-angiotensin aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006;98:121\u20138.","journal-title":"Am J Cardiol"},{"key":"252_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10557-010-6256-6","volume":"24","author":"FA Martinez","year":"2010","unstructured":"Martinez FA. Aldosterone inhibition and cardiovascular protection: more important than it once appeared. Cardiovasc Drugs Ther. 2010;24:345\u201350.","journal-title":"Cardiovasc Drugs Ther"},{"key":"252_CR34","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1210\/en.2010-0350","volume":"151","author":"T Cascella","year":"2010","unstructured":"Cascella T, Radhakrishnan Y, Maile LA, Walker H, Busby J, Gollahon K, et al. Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells. Endocrinology. 2010;151:5851\u201364.","journal-title":"Endocrinology"},{"key":"252_CR35","first-page":"1989417","volume":"2017","author":"SH Nam","year":"2017","unstructured":"Nam SH, Kang SG, Song SW. The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a crosssectional study. Biomed Res Int. 2017;2017:1989417.","journal-title":"Biomed Res Int"},{"key":"252_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1586\/14779072.2014.902309","volume":"12","author":"S Balta","year":"2014","unstructured":"Balta S, Kurtoglu E, Kucuk U, Demirkol S, \u00d6zt\u00fcrk C. Neutrophil-lymphocyte ratio as an important assessment tool. Expert Rev Cardiovasc Ther. 2014;12:537\u20138.","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"252_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3109\/10641963.2012.758734","volume":"35","author":"M Karaman","year":"2013","unstructured":"Karaman M, Balta S, Seyit Ahmet AY, Cakar M, Naharci I, Demirkol S, et al. The comparative effects of valsartan and amlodipine on vWf levels and N\/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens. 2013;35:516\u201322.","journal-title":"Clin Exp Hypertens"},{"key":"252_CR38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","volume":"45","author":"BD Horne","year":"2005","unstructured":"Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45:1638\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"252_CR39","doi-asserted-by":"publisher","first-page":"689360","DOI":"10.1155\/2014\/689360","volume":"2014","author":"M Pacurari","year":"2014","unstructured":"Pacurari M, Kafoury R, Tchounwou PB, Ndebele K. The renin\u2013angiotensin\u2013aldosterone system in vascular inflammation and remodeling. Int J Inflam. 2014;2014:689360.","journal-title":"Int J Inflam."},{"key":"252_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2015.04.011","volume":"83","author":"A Harvey","year":"2015","unstructured":"Harvey A, Montezano AC, Touyz RM. Vascular biology of ageing\u2014implications in hypertension. J Mol Cell Cardiol. 2015;83:112\u201321.","journal-title":"J Mol Cell Cardiol"},{"key":"252_CR41","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","volume":"70","author":"TJ Guzik","year":"2017","unstructured":"Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70:660\u20137.","journal-title":"Hypertension"},{"key":"252_CR42","doi-asserted-by":"publisher","first-page":"15918","DOI":"10.3390\/ijms160715918","volume":"16","author":"Y Mikhed","year":"2015","unstructured":"Mikhed Y, Daiber A, Steven S. Mitochondrial oxidative stress, mitochondrial DNA damage and their role in age-related vascular dysfunction. Int J Mol Sci. 2015;16:15918\u201353.","journal-title":"Int J Mol Sci"},{"key":"252_CR43","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1073\/pnas.051627098","volume":"98","author":"JE Kokoszka","year":"2001","unstructured":"Kokoszka JE, Coskun P, Esposito LA, Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (\u00b1) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA Natl Acad Sci. 2001;98:2278\u201383.","journal-title":"Proc Natl Acad Sci USA Natl Acad Sci"},{"key":"252_CR44","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1089\/ars.2013.5607","volume":"20","author":"A Konior","year":"2014","unstructured":"Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ. NADPH oxidases in vascular pathology. Antioxid Redox Signal. 2014;20:2794\u2013814.","journal-title":"Antioxid Redox Signal"},{"key":"252_CR45","doi-asserted-by":"publisher","first-page":"H363","DOI":"10.1152\/ajpheart.01134.2010","volume":"301","author":"Z Ungvari","year":"2011","unstructured":"Ungvari Z, Bailey-Downs L, Sosnowska D, Gautam T, Koncz P, Losonczy G, et al. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response. AJP Hear Circ Physiol. 2011;301:H363\u201372.","journal-title":"AJP Hear Circ Physiol."},{"key":"252_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","volume":"164","author":"U F\u00f6rstermann","year":"2011","unstructured":"F\u00f6rstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol. 2011;164:213\u201323.","journal-title":"Br J Pharmacol"},{"key":"252_CR47","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1096\/fj.201500088R","volume":"30","author":"TP Mikolajczyk","year":"2016","unstructured":"Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D, et al. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J. 2016;30:1987\u201399.","journal-title":"FASEB J."},{"key":"252_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1476-511X-9-66","volume":"9","author":"X-F Leong","year":"2010","unstructured":"Leong X-F, Mustafa MR, Das S, Jaarin K. Association of elevated blood pressure and impaired vasorelaxation in experimental Sprague-Dawley rats fed with heated vegetable oil. Lipids Health Dis. 2010;9:66.","journal-title":"Lipids Health Dis."},{"key":"252_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cvr\/cvv221","volume":"108","author":"L-M Yung","year":"2015","unstructured":"Yung L-M, S\u00e1nchez-Duffhues G, ten Dijke P, Yu PB. Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells. Cardiovasc Res. 2015;108:278\u201387.","journal-title":"Cardiovasc Res"},{"key":"252_CR50","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1161\/ATVBAHA.107.146852","volume":"27","author":"KA Brown","year":"2007","unstructured":"Brown KA, Didion SP, Andresen JJ, Faraci FM. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler Thromb Vasc Biol Am Heart Assoc. 2007;27:1941\u20136.","journal-title":"Arterioscler Thromb Vasc Biol Am Heart Assoc"},{"key":"252_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.lfs.2009.11.020","volume":"86","author":"CM Ferrario","year":"2010","unstructured":"Ferrario CM. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control. Life Sci. 2010;86:289\u201399.","journal-title":"Life Sci"},{"key":"252_CR52","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547\u201359.","journal-title":"N Engl J Med"},{"key":"252_CR53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cphy.c100053","volume":"1","author":"NE Rhaleb","year":"2011","unstructured":"Rhaleb NE, Yang XP, Carretero OA. The Kallikrein-Kinin system as a regulator of cardiovascular and renal function. Compr Physiol. 2011;1:971\u201393.","journal-title":"Compr Physiol."},{"key":"252_CR54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0031-6997(25)06820-6","volume":"47","author":"W Linz","year":"1995","unstructured":"Linz W, Wiemer G, Gohlke P, Unger T, Scholkens B. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25\u201349.","journal-title":"Pharmacol Rev"},{"key":"252_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1753944716644131","volume":"10","author":"R D\u00fcsing","year":"2016","unstructured":"D\u00fcsing R. Mega clinical trials which have shaped the RAS intervention clinical practice. Ther Adv Cardiovasc Dis. 2016;10:133\u201350.","journal-title":"Ther Adv Cardiovasc Dis."},{"key":"252_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijcard.2016.06.053","volume":"219","author":"MCS Wong","year":"2016","unstructured":"Wong MCS, Chan DKL, Wang HHX, Tam WWS, Cheung CSK, Yan BP, et al. The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: a cohort study. Int J Cardiol. 2016;219:410\u20136.","journal-title":"Int J Cardiol"},{"key":"252_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2011.12.005","volume":"221","author":"Y Shahin","year":"2012","unstructured":"Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18\u201333.","journal-title":"Atherosclerosis."},{"key":"252_CR58","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","volume":"33","author":"LC Vark Van","year":"2012","unstructured":"Van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J. 2012;33:2088\u201397.","journal-title":"Eur Heart J"},{"key":"252_CR59","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1161\/01.CIR.100.22.2267","volume":"100","author":"HD Intengan","year":"1999","unstructured":"Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999;100:2267\u201375.","journal-title":"Circulation"},{"key":"252_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3317\/jraas.2001.006","volume":"2","author":"W Wojakowski","year":"2001","unstructured":"Wojakowski W, Gminski J, Siemianowicz K, Goss M, Machalski M. The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits. J Renin Angiotensin Aldosterone Syst. 2001;2:37\u201342.","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"252_CR61","first-page":"91","volume":"26","author":"RM Carey","year":"2017","unstructured":"Carey RM. Update on angiotensin AT2 receptors. Curr Opin Nephrol Hypertens. 2017;26:91\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"252_CR62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ajh\/hpw121","volume":"30","author":"RM Carey","year":"2017","unstructured":"Carey RM. AT2 receptors: potential therapeutic targets for hypertension. Am J Hypertens. 2017;30:339\u201347.","journal-title":"Am J Hypertens"},{"key":"252_CR63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.CIR.0000096609.73772.C5","volume":"109","author":"BI L\u00e9vy","year":"2004","unstructured":"L\u00e9vy BI. Can angiotensin II Type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation. 2004;109:8\u201313.","journal-title":"Circulation"},{"key":"252_CR64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","volume":"104","author":"S Ichihara","year":"2001","unstructured":"Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 2001;104:346\u201351.","journal-title":"Circulation"},{"key":"252_CR65","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1172\/JCI10037","volume":"106","author":"T Senbonmatsu","year":"2000","unstructured":"Senbonmatsu T, Ichihara S, Price E, Gaffney FA, Inagami T. Evidence for angiotensin II type 2 receptor\u2013mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest. 2000;106:R25\u20139.","journal-title":"J Clin Invest."},{"key":"252_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50:89\u201399.","journal-title":"J Vasc Res"},{"key":"252_CR67","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.115.07074","volume":"67","author":"M Briet","year":"2016","unstructured":"Briet M, Barhoumi T, Mian MOR, Coelho SC, Ouerd S, Rautureau Y, et al. Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors novelty and significance. Hypertension. 2016;67:897\u2013905.","journal-title":"Hypertension"},{"key":"252_CR68","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1096\/fj.13-228312","volume":"27","author":"V Druppel","year":"2013","unstructured":"Druppel V, Kusche-Vihrog K, Grossmann C, Gekle M, Kasprzak B, Brand E, et al. Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome. FASEB J. 2013;27:3652\u20139.","journal-title":"FASEB J."},{"key":"252_CR69","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/CS20140758","volume":"129","author":"MAB Silva","year":"2015","unstructured":"Silva MAB, Cau SBA, Lopes RAM, Manzato CP, Neves KB, Bruder-Nascimento T, et al. Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type\u00a02 diabetes mellitus. Clin Sci. 2015;129:533\u201345.","journal-title":"Clin Sci"},{"key":"252_CR70","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","volume":"51","author":"C Savoia","year":"2008","unstructured":"Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension. 2008;51:432\u20139.","journal-title":"Hypertension"},{"key":"252_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","volume":"18","author":"A Mahmud","year":"2005","unstructured":"Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18:50\u20135.","journal-title":"Am J Hypertens"},{"key":"252_CR72","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","volume":"41","author":"WB White","year":"2003","unstructured":"White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J, et al. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension. 2003;41:1021\u20136.","journal-title":"Hypertension"},{"key":"252_CR73","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.exger.2013.05.058","volume":"48","author":"M-H Hwang","year":"2013","unstructured":"Hwang M-H, Yoo J-K, Luttrell M, Kim H-K, Meade TH, English M, et al. Role of mineralocorticoid receptors in arterial stiffness in human aging. Exp Gerontol. 2013;48:701\u20134.","journal-title":"Exp Gerontol"},{"key":"252_CR74","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrneph.2011.29","volume":"7","author":"N Nobakht","year":"2011","unstructured":"Nobakht N, Kamgar M, Rastogi A, Schrier RW. Limitations of angiotensin inhibition. Nat Rev Nephrol. 2011;7:356\u20139.","journal-title":"Nat Rev Nephrol."},{"key":"252_CR75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/01.HYP.0000253780.36691.4f","volume":"49","author":"E O\u2019Brien","year":"2007","unstructured":"O\u2019Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, et al. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension. 2007;49:276\u201384.","journal-title":"Hypertension"},{"key":"252_CR76","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/eurheartj\/ehs057","volume":"33","author":"A Virdis","year":"2012","unstructured":"Virdis A, Ghiadoni L, Qasem AA, Lorenzini G, Duranti E, Cartoni G, et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012;33:1530\u20138.","journal-title":"Eur Heart J"},{"key":"252_CR77","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","volume":"374","author":"JJV McMurray","year":"2016","unstructured":"McMurray JJV, Krum H, Abraham WT, Dickstein K, K\u00f8ber LV, Desai AS, et al. Aliskiren, Enalapril, or Aliskiren and enalapril in heart failure. N Engl J Med. 2016;374:1521\u201332.","journal-title":"N Engl J Med"},{"key":"252_CR78","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1124\/pr.113.008425","volume":"66","author":"HJ Solinski","year":"2014","unstructured":"Solinski HJ, Gudermann T, Breit A. Pharmacology and signaling of MAS-related G protein-coupled receptors. Pharmacol Rev. 2014;66:570\u201397.","journal-title":"Pharmacol Rev"},{"key":"252_CR79","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RAS Santos","year":"2003","unstructured":"Santos RAS, e Silva ACS, Maric C, Silva DMR, Machado RP, de Buhr L, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci. 2003;100:8258\u201363.","journal-title":"Proc Natl Acad Sci"},{"key":"252_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","volume":"47","author":"CM Ferrario","year":"2006","unstructured":"Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension. 2006;47:515\u201321.","journal-title":"Hypertension"},{"key":"252_CR81","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","volume":"50","author":"MC Chappell","year":"2007","unstructured":"Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension. 2007;50:596\u20139.","journal-title":"Hypertension"},{"key":"252_CR82","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","volume":"98","author":"U Danilczyk","year":"2006","unstructured":"Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res. 2006;98:463\u201371.","journal-title":"Circ Res"},{"key":"252_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"XC Li","year":"2017","unstructured":"Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017;125:21\u201338.","journal-title":"Pharmacol Res"},{"key":"252_CR84","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tips.2015.03.001","volume":"36","author":"DG Passos-Silva","year":"2015","unstructured":"Passos-Silva DG, Brandan E, Santos RAS. Angiotensins as therapeutic targets beyond heart disease. Trends Pharmacol Sci. 2015;36:310\u201320.","journal-title":"Trends Pharmacol Sci"},{"key":"252_CR85","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","volume":"310","author":"MC Chappell","year":"2016","unstructured":"Chappell MC. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Hear Circ Physiol. 2016;310:H137\u201352.","journal-title":"Am J Physiol Hear Circ Physiol."},{"key":"252_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","volume":"125","author":"E Kaschina","year":"2017","unstructured":"Kaschina E, Namsolleck P, Unger T. AT2 receptors in cardiovascular and renal diseases. Pharmacol Res. 2017;125:39\u201347.","journal-title":"Pharmacol Res"},{"key":"252_CR87","doi-asserted-by":"publisher","first-page":"F1024","DOI":"10.1152\/ajprenal.00221.2005","volume":"290","author":"XC Li","year":"2006","unstructured":"Li XC, Campbell DJ, Ohishi M, Yuan S, Zhuo JL. AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats. Am J Physiol Ren Physiol. 2006;290:F1024\u201333.","journal-title":"Am J Physiol Ren Physiol."},{"key":"252_CR88","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCRESAHA.115.304110","volume":"115","author":"BA Kemp","year":"2014","unstructured":"Kemp BA, Howell NL, Gildea JJ, Keller SR, Padia SH, Carey RM. AT2 receptor activation induces natriuresis and lowers blood pressure. Circ Res. 2014;115:388\u201399.","journal-title":"Circ Res"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-018-0252-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:04:52Z","timestamp":1751414692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-018-0252-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s40292-018-0252-5","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and\/or animals rights"}},{"value":"This article is a Review and informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}